论文部分内容阅读
目的探讨牙周病患者治疗前后血浆生物标志物水平变化的临床意义。方法利用放射免疫分析(RIA)和超敏酶免疫分析测定85例牙周病患者(牙周病组)治疗前后血浆IL-6、IL-8、TNF-α和超敏c-反应蛋白(hs-CRP)的水平,并与54例正常对照组进行比较。结果牙周病患者治疗前血浆IL-6、IL-8、TNF-α和hs-CRP的水平与正常对照组相比差异有高度统计学意义(均P<0.01),治疗后血浆生物标志物水平恢复至正常水平。与正常对照组相比,差异均无统计学意义(均P>0.05)。结论牙周病患者血浆IL-6、IL-8、TNF-α和hs-CRP水平测定是牙周病考核疗效的有效指标。
Objective To investigate the clinical significance of plasma biomarkers before and after treatment in patients with periodontal disease. Methods Serum levels of IL-6, IL-8, TNF-α and hs (hs) were measured in 85 patients with periodontal disease (periodontal disease) before and after treatment by radioimmunoassay (RIA) -CRP), and compared with 54 normal control group. Results The levels of plasma IL-6, IL-8, TNF-α and hs-CRP in patients with periodontal disease before treatment were significantly higher than those in normal control group (all P <0.01). After treatment, plasma biomarkers The level returned to normal levels. Compared with the normal control group, there was no significant difference (all P> 0.05). Conclusion The determination of plasma IL-6, IL-8, TNF-α and hs-CRP levels in patients with periodontal disease is an effective indicator of the effect of periodontal disease assessment.